UCB and Biogen report positive results for lupus drug dapirolizumab pegol

Go back to UCB and Biogen report positive results for lupus drug dapirolizumab pegol
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 199.71 --0 (-0%)
Previous Close $199.71    52 Week High $333.65 
Open $199.71    52 Week Low $223.02 
Day High $199.71    P/E 25.57 
Day Low $199.71    EPS $7.81 
Volume 2,067